Skip to application
All calculators and tools

Preparation. Administration. Evidence.

IV Dilution &
Medication Reference

Search 255 medications, read preserved historical references, and inspect separately reviewed preparation statements. Full monograph updates remain pending.

Version 6.4Release date 2026-11-04For healthcare professionals
Back to resultsA-Z list

Medication reference

Vasopressin

Monograph awaiting updateThis monograph will be updated in the future.

Jump to a section

Historical source. Current clinical review is incomplete. This monograph will be updated in the future.

Vasopressin - Pitressin ® (opens in a new tab)Original source URL: https://globalrph.com/dilution/vasopressin-pitressin/ | Retrieved 2026-11-04

Source dates, location and integrity

This historical article is separate from the reviewed claim cards. Product formulations and source dates may differ.

Original source URL
https://globalrph.com/dilution/vasopressin-pitressin/ (opens in a new tab)
Source date
Not established in the retrieved source
Retrieved
2026-11-04T19:50:19.087698+00:00
Source location
div.post-content
Packaged content SHA-256
b3cb2cf1b6aa96eea18232909cf65a5e8e4c72e00fdc3ae894930606da1c62ad
Original response SHA-256
72c50fc0a19e3ef38b438a1cbfcb670749262f00bd07e8ac948c6c63f5723b83
Source body SHA-256
137bf4ebdce9ebe72fbfcf2f265632a92a252281fdf4e97619ddb981f22ec2b8

Vasopressin (Pitressin ®)

The authors make no claims of the accuracy of the information contained herein; and these suggested doses and/or guidelines are not a substitute for clinical judgment. Neither GlobalRPh Inc. nor any other party involved in the preparation of this document shall be liable for any special, consequential, or exemplary damages resulting in whole or part from any user's use of or reliance upon this material. PLEASE READ THE DISCLAIMER CAREFULLY BEFORE ACCESSING OR USING THIS SITE. BY ACCESSING OR USING THIS SITE, YOU AGREE TO BE BOUND BY THE TERMS AND CONDITIONS SET FORTH IN THE DISCLAIMER.

Usual Diluents

NS, D5W

Standard Dilutions [Amount of drug] [Infusion volume] [Infusion rate]

Acceptable concentration: (0.1 - 1.0 u/ ml)
[100 units] [100 to 500 ml]
[200 units] [250 ml]
Infusion rate: as directed

ICU - Vasodilatory shock/septic shock
[40 units ] [100 ml ] [0.01 - 0.03 units/minute]
Rates:
0.01 units/minute = 1.5 ml/hr
0.02 units/minute = 3 ml/hr
0.03 units/minute = 4.5 ml/hr

Doses greater than 0.04 units/min may lead to cardiac arrest. Rapid rebound hypotension is a common problem after treatment with vasopressin is stopped. Ideally, vasopressin should be
tapered slowly by 0.01 unit/minute increments before discontinuing. Background info.

Stability / Miscellaneous

Stability: Trissels: No drug-solution combinations have been tested. [2010]

"Antidiuretic hormone"

Dosing (adults):
Diabetes insipidus: 5-10u IM/SC 2 to 4 times/day as needed.
Abdominal distention: 5 units IM stat, followed by 10 units q3-4h.

Vasodilatory shock/septic shock: Vasopressin may be used in patients with refractory shock despite adequate fluid resuscitation and the use of high-dose conventional catecholamines such as norepinephrine and dopamine, however, further studies are needed to determine its exact place in therapy. Current evidence does not support the use of vasopressin as a replacement for norepinephrine or dopamine as a first-line agent. The recommended infusion rate for vasopressin in the treatment of shock in adults is 0.01- 0.03 units/min. This dosage range is reported to be effective in about 85% of patients with norepinephrine resistant hypotension. Doses greater than 0.04 units/min may lead to cardiac arrest.

Bleeding esophageal varices and other types of upper GI bleeds:
initially 0.2 u/min, then increase each hour by 0.2 u/min until the hemorrhage is controlled. Doses as high as 2 u/min may be tolerated, but a more prudent dosage limit is 1 u/min. After 12 hours of control of the hemorrhage the dose of vasopressin may be decreased by 50%, then may discontinue in the next 12-24 hrs. Intravenous nitroglycerin should be administered concomitantly to control side effects.

MOA: ADH and pressor activity. Portal blood pressure is significantly decreased. A decrease in porto-systemic collateral flow and an increase in the muscular tone of the lower esophagus reduces blood flow to esophageal varices. The smooth muscle of the GI tract is also effected by large doses and peristaltic activity of the bowel and smooth muscles of the uterus are stimulated.


INDICATIONS
Vasopressin is indicated for prevention and treatment of postoperative abdominal distention, in abdominal roentgenography to dispel interfering gas shadows, and in diabetes insipidus.

DOSAGE AND ADMINISTRATION
Vasopressin may be administered intramuscularly or subcutaneously.

Ten units of vasopressin (0.5mL) will usually elicit full physiologic response in adult patients: 5units will be adequate in many cases. Vasopressin should be given intramuscularly at three-or four-hour intervals as needed. The dosage should be proportionately reduced for children.(For an additional discussion of dosage, consult the sections below.)

When determining the dose of vasopressin for a given case, the following should be kept in mind.

It is particularly desirable to give a dose not much larger than is just sufficient to elicit the desired physiologic response. Excessive doses may cause undesirable side effects - blanching of the skin, abdominal cramps, nausea, which, though not serious, may be alarming to the patient. Spontaneous recovery from such side effects occurs in a few minutes. It has been found that one or two glasses of water given at the time vasopressin is administered reduce such symptoms.

Abdominal Distention: In the average postoperative adult patient, give 5 units (0.25 mL) initially, increase to 10 units (0.5mL) at subsequent injections if necessary. It is recommended that vasopressin be given intramuscularly and that injections be repeated at three-or four-hour intervals as required. Dosage to be reduced proportionately for children.

Vasopressin used in this manner will frequently prevent or relieve postoperative distension. These recommendations apply also to distention complicating pneumonia or other acute toxemias.

Abdominal Roentgenography: For the average case, two injections of 10 units each (0.5 mL) are suggested . These should be given two hours and one-half hour, respectively, before films are exposed. Many roentgenologists advise giving an enema prior to the first dose of vasopressin.

Diabetes Insipidus: Vasopressin may be given by injection or administered intranasally on cotton pledgets, by nasal spray, or by dropper. The dose by injection is 5 to 10 units (0.25 to 0.5mL) repeated two or three times daily as needed. When vasopressin is administered intranasally by spray or on pledgets, the dosage and interval between treatments must be determined for each patient.

Parenteral drug products should be inspected visually for particulate matter and discoloration prior to use, whenever solution and container permit.

HOW SUPPLIED
Vasopressin Injection, USP 20units/L is supplied as follows:

For intramuscular or subcutaneous use:

10 units per 0.5 mL multiple dose vial Boxes of 25
20 units per 1mL multiple dose vial Boxes of 25
200 units per 10 mL multiple dose vial Boxes of 10

Store at controlled room temperature 15°-30° C (59°-86° F).

Source: [package insert]

Open this historical article on its own

Product identifiers and clinical review status

This monograph will be updated in the future. Historical material is available where present in the original sources; full current exact-product and claim-level review remains pending.

Exact formulation, concentration, container, manufacturer, regulatory identifiers, and a reproducible label snapshot have not all been reconciled.

What remains to be completed
  • Retrievable exact-product SPL XML with version, revision, retrieval date and reproducible hash
  • Clinically reviewed, individually identified statements with two exact source mappings
  • Exact formulation, strength, container, manufacturer/labeler, application and NDC reconciliation
  • Renal-function methods and dialysis/CRRT modality review where applicable
  • Mechanism provenance, clinical source disagreements and full medication-specific safety reconciliation

Supplemental historical fields

Restored-data provenance and review notes

Source release: 2026-08-31. Current clinical review is incomplete. Original uses of current, verified, or normalized describe the historical source. They do not inherit the status of separately reviewed statements. Product formulations and source dates can differ.

Current review annotations for historical renal, dialysis, mechanism, and product fieldsSeparate renal reference: Open Renal Dosing Master (opens in a new tab)
Renal
Status
not_locally_normalized
Original classification
no_routine_adjustment_identified
Entries
    General note
    Preserve the source-specific renal-function basis. An indexed CrCl table is not interchangeable with unindexed CrCl or eGFR. Generic advice to check a method does not identify the equation for a dose row.
    Dialysis
    Status
    no_local_structured_regimen
    Entries
      General note
      Named modality alone does not establish applicability. CRRT subtype, effluent rate, residual renal function, timing and interruptions require review. Historical absence is not evidence that no guidance exists.
      Mechanisms
      • Source kind
        first_look
        Local pointer
        /mechanism
        Original level
        drug_specific
        Provenance classification
        historical_drug_specific_uncorroborated
        Label derived verified
        false
        Independently corroborated
        false
        Exact label section
        Not recorded
        Original source note
        Not recorded
        Review status
        historical_unverified
        Note
        Drug-specific wording in the old file is not proof of independent corroboration or an exact label locator. Consult separately published current mechanism claims where present.
      Future update
      Status
      pending_review
      Message
      This monograph will be updated in the future as current exact-product and claim-level review is completed.
      Source unavailable
      false
      Reason
      The historical content is restored; comprehensive contemporary verification remains incomplete.
      Historical first look: uses, mechanism, dosing context, and administration

      Recovered v5.1 source content; historical, awaiting current review.

      Id
      vasopressin
      Source IDH51-380EE1528268766573D5D1D6
      Generic name
      Vasopressin
      Source IDH51-5CFC6F6CAAD86E99087CCB85
      Class
      Cardiovascular and vasoactive
      Source IDH51-B0BC4FF72E24C11883B1E462
      Subclass
      Vasopressin receptor agonist
      Source IDH51-F0CADFE54AB210D05F7354E1
      Primary uses
      1. Vasodilatory shock
        Source IDH51-0875F1126AF86637CD369DCD
      2. Selected vasoplegia and bleeding protocols
        Source IDH51-83E050BFE535ECF049E0AE30
      Mechanism
      Activates vascular V1 and renal V2 receptors, producing vasoconstriction and water reabsorption.
      Source IDH51-1E111492EBCBE3CF7AE4518E
      Mechanism level
      drug_specific
      Source IDH51-34DAC26CB8EE9F4C1DC73100
      Basic dosing orientation
      Adult septic shock infusion | Existing preparation record; use current package insert for indication-specific selection | Common bag 20 units | Not normalized in the preparation record | See current package insert and professional guidance | IV infusion; Pediatric and neonatal infusion | Existing preparation record; use current package insert for indication-specific selection | Weight-based protocol | Not normalized in the preparation record | See current package insert and professional guidance | IV infusion
      Source IDH51-65FDC08A4549D8BEAA18A47F
      Administration orientation
      Common fixed rate 0.03 unit/min; Titrate or fixed rate per indication-specific protocol; 20 units/100 mL (0.2 unit/mL); 0.03 unit/min commonly; Often fixed rather than titrated; follow local shock protocol
      Source IDH51-5E02C706B9A5364FD775139B
      Renal and population orientation
      Separate renal reference: Open Renal Dosing Master (opens in a new tab)No routine renal adjustment is commonly used for many indications, but verify the current label and clinical context.
      Source IDH51-D1A5FCA936421F5407018FAC
      Key safety orientation
      1. Digital, mesenteric, cardiac, and skin ischemia.
        Source IDH51-76CC53255019A4C6C2BCDB48
      2. Hyponatremia can occur.
        Source IDH51-4992ECEE8CAD216847A77AD0
      3. Units/min and units/hour errors are dangerous.
        Source IDH51-D475572FE4F34E3B92DA1613
      Coverage path
      structured_local_snapshot
      Source IDH51-DD624643CAED2254A188A791
      Coverage path label
      Structured GlobalRPh route snapshot
      Source IDH51-B93784ACE3FECCCDB1D0BFF4
      Legacy title
      Vasopressin
      Source IDH51-6C516B977EF183332BD95053
      Review note
      First-look orientation only. Verify indication, patient population, weight basis, organ function, exact IV product, dose, concentration, compatibility, rate, and current labeling before use.
      Source IDH51-9D7FF592AB1887658C4674E8
      Search text
      Vasopressin Cardiovascular and vasoactive Vasopressin receptor agonist Vasodilatory shock Selected vasoplegia and bleeding protocols Activates vascular V1 and renal V2 receptors, producing vasoconstriction and water reabsorption. Adult septic shock infusion | Existing preparation record; use current package insert for indication-specific selection | Common bag 20 units | Not normalized in the preparation record | See current package insert and professional guidance | IV infusion; Pediatric and neonatal infusion | Existing preparation record; use current package insert for indication-specific selection | Weight-based protocol | Not normalized in the preparation record | See current package insert and professional guidance | IV infusion Common fixed rate 0.03 unit/min; Titrate or fixed rate per indication-specific protocol; 20 units/100 mL (0.2 unit/mL); 0.03 unit/min commonly; Often fixed rather than titrated; follow local shock protocol No routine renal adjustment is commonly used for many indications, but verify the current label and clinical context. Digital, mesenteric, cardiac, and skin ischemia. Hyponatremia can occur. Units/min and units/hour errors are dangerous. Structured GlobalRPh route snapshot
      Source IDH51-2FBF341047D4A3C7AAAF9AE4
      Official access mode
      search
      Source IDH51-C6DE719B9902CE0A93EFD146
      Official search query
      Vasopressin
      Source IDH51-5AECCE55747F664F68079C99
      Official access reason
      A source-backed DailyMed search is available; select and confirm the exact IV product.
      Source IDH51-31635B2C157347DBEB80CBCB

      No separate structured rows were bundled for IV push, dialysis, CRRT. Historical article content and source links may cover these topics.

      Historical dilution and intermittent infusion preparation

      Recovered v5.1 source content; historical, awaiting current review.

      PopulationAmountReconstitutionDiluentFinal volumeConcentrationRateStabilityNotes
      Source IDH51-8F87815B272899218CE6D087
      Adult septic shock infusion
      Source IDH51-3D8EC35D9F4B4D3010AB5D19
      Common bag 20 units
      Source IDH51-E52EAB0B942098245A981658
      Dilute vial or use premix.
      Source IDH51-27C8D01645AD1D1A4B98BCDE
      NS or D5W
      Source IDH51-E0874F430E64E241371279C9
      100 mL
      Source IDH51-CB37001990A6AF139E8CCEAD
      0.2 unit/mL
      Source IDH51-6358E37A49026F22EAF552C6
      Common fixed rate 0.03 unit/min
      Source IDH51-5315F14F5B11CF3E53444B10
      Use the shorter of current product labeling, validated stability data, and the applicable USP <797> sterility-based BUD ceiling.
      Source IDH51-679DF8714AE70071A859903B
      Do not extrapolate shock dosing to variceal bleeding or other indications.
      Source IDH51-04B84FC21C0E50D66F4499E5
      Source IDH51-71BC2188A660925F3B932E49
      Pediatric and neonatal infusion
      Source IDH51-7EF1599594CC48AB287E4696
      Weight-based protocol
      Source IDH51-A179F98797F122C43A29B95E
      Pharmacy-prepared standardized concentration.
      Source IDH51-1DF11664FF4B293022E017E7
      Compatible fluid
      Source IDH51-EF5B103D1A1100BB5A18EF6E
      Weight-appropriate volume
      Source IDH51-AF0FF22C015116C574BDEAD3
      Institution-specific
      Source IDH51-011BAF2AEB94DF0C07A7A3EF
      Titrate or fixed rate per indication-specific protocol
      Source IDH51-FEC09219C7048EC3222A888C
      Use the shorter of current product labeling, validated stability data, and the applicable USP <797> sterility-based BUD ceiling.
      Source IDH51-CE0C6C0881B86B7B9C94EDD5

      Historical continuous-infusion guidance

      Recovered v5.1 source content; historical, awaiting current review.

      PopulationStandard concentrationInitial rateTitrationMaximumNotes
      Source IDH51-599D3E7EC6D93D8A49F442E6
      Adult septic shock
      Source IDH51-6C412FE8E5A27B96A46E596A
      20 units/100 mL (0.2 unit/mL)
      Source IDH51-5589F16B01187B49FD39CF0A
      0.03 unit/min commonly
      Source IDH51-F81E8500AE648DD8F3EA56AF
      Often fixed rather than titrated; follow local shock protocol
      Source IDH51-C1E12750548938499D953695
      Commonly 0.04 unit/min in shock protocols
      Source IDH51-1A1BB90DADC299D40189A686
      Higher doses increase ischemic risk and require explicit authorization.
      Source IDH51-09BF97BC4975CA3DA637ACBA

      Historical indication and population dosing

      Recovered tables and source-separated snapshots; full clinical revalidation remains pending.

      Existing dose and route snapshots

      RoutePopulationIndicationDoseIntervalDurationAdministrationSource levelNotes
      Source IDH51-8D9194CF36140A96EABA7B0A
      IV infusion
      Source IDH51-43A3FF06BDD7B225088C59D1
      Adult septic shock infusion
      Source IDH51-529A2C032E485F1535C5A49A
      Existing preparation record; use current package insert for indication-specific selection
      Source IDH51-0639425B53531B68E9BF7742
      Common bag 20 units
      Source IDH51-3334F138C4439404A1B7D38B
      Not normalized in the preparation record
      Source IDH51-493AB528BA0367515DAB666B
      See current package insert and professional guidance
      Source IDH51-A142C45539B46827767F69B0
      Common fixed rate 0.03 unit/min
      Source IDH51-D8FA0ED7A4AAA1164CF7D5B4
      Existing GlobalRPh structured preparation snapshot
      Source IDH51-2437E9EF66532F24BBC69C8F
      Do not extrapolate shock dosing to variceal bleeding or other indications.
      Source IDH51-F0A73D346CAB6B0F1050A283
      Source IDH51-76D35FC5190376DF7AEA8033
      IV infusion
      Source IDH51-E639EAA007A96140C730E7F8
      Pediatric and neonatal infusion
      Source IDH51-19B29C528D55F3228C46CA82
      Existing preparation record; use current package insert for indication-specific selection
      Source IDH51-D983480CE0C15AFE25F84096
      Weight-based protocol
      Source IDH51-B75840327126F4510990E064
      Not normalized in the preparation record
      Source IDH51-632FC394C82A98666F77F3E4
      See current package insert and professional guidance
      Source IDH51-273328EC7281385767A433C8
      Titrate or fixed rate per indication-specific protocol
      Source IDH51-41EA86F535F4FA7F5EBEA23C
      Existing GlobalRPh structured preparation snapshot
      Source IDH51-7D1CA5C2B00DA6EDEAA0D1AE
      Source IDH51-CE12BD59697D4889CB5F1D46
      Continuous IV infusion
      Source IDH51-8A46714D2B6AB537FECF39A3
      Adult septic shock
      Source IDH51-859E51EC8022D7BA338525F4
      Existing continuous-infusion record
      Source IDH51-1846916BD5A6687707800179
      0.03 unit/min commonly
      Source IDH51-8AE642274A60AC2120B1F9B7
      Continuous infusion; titration-specific
      Source IDH51-7AE4DAF9ABFBE69926AEF0F4
      Clinical-response dependent
      Source IDH51-220B7C80F355E8039E10D60D
      Often fixed rather than titrated; follow local shock protocol
      Source IDH51-6EA7410B6F31DCEF61069527
      Existing GlobalRPh continuous-infusion snapshot
      Source IDH51-D378C00E30F10F6CD8F9E037
      Commonly 0.04 unit/min in shock protocols Higher doses increase ischemic risk and require explicit authorization.
      Source IDH51-D739616FDCED51596F2FAE7F

      Historical renal-function guidance

      Recovered v5.1 source content; historical, awaiting current review.

      Separate renal reference: Open Renal Dosing Master (opens in a new tab)
      Classification
      no_routine_adjustment_identified
      Source IDH51-61335D390115D6D487C96ECD
      Summary
      No routine renal adjustment is commonly used for many indications, but verify the current label and clinical context.
      Source IDH51-749CA8C9A2EDC0D692D527AD
      Method note
      Use the renal function estimate and body-size convention specified by the selected label or institutional protocol. Do not interchange Cockcroft-Gault CrCl, indexed eGFR, and de-indexed eGFR without confirming the dosing source.
      Source IDH51-08D463AF1900879AB53927ED

      Historical Common IV uses

      Recovered v5.1 source content; historical, awaiting current review.

      1. Vasodilatory shock
        Source IDH51-3107A173A52FD75E3DAB6C3A
      2. Selected vasoplegia and bleeding protocols
        Source IDH51-8A443FD7B0C533323E33A423

      Historical Warnings and safeguards

      Recovered v5.1 source content; historical, awaiting current review.

      1. Digital, mesenteric, cardiac, and skin ischemia.
        Source IDH51-3DDE505FCC560D2F6749BB9B
      2. Hyponatremia can occur.
        Source IDH51-454115018F2D2A38371B8B84
      3. Units/min and units/hour errors are dangerous.
        Source IDH51-4BC7FFD537E2F242D24DA64D

      Historical Monitoring

      Recovered v5.1 source content; historical, awaiting current review.

      1. Blood pressure and perfusion
        Source IDH51-CA8ABDEB3FCEBBF4E26A6576
      2. Serum sodium
        Source IDH51-F84CD59D5E07EDE9D91FAD3C
      3. Cardiac and peripheral ischemia
        Source IDH51-588C4294C797684A51A77840
      Other recovered source fields and original editorial metadata

      Original status words such as current, verified, or normalized describe the historical source release. They do not change the clinical review status of this release.

      Catalog source fields

      Id
      vasopressin
      Source IDH51-CD8AF9E8778288718B5FC435
      Generic name
      Vasopressin
      Source IDH51-D2F4FF330F7BC6D5BF25C2FB
      Brand names
      1. Vasostrict
        Source IDH51-1DBB98C254EF3B5208B36993
      2. Pitressin
        Source IDH51-127B81CD3FB8DF9E45CF0A2C
      Class
      Cardiovascular and vasoactive
      Source IDH51-9EABF5AB059E40DB6482F56B
      Subclass
      Vasopressin receptor agonist
      Source IDH51-4C8E03117E46F908605B0314
      Summary
      High-alert vasopressor commonly used as a fixed-dose adjunct in vasodilatory shock; other indications use different concentrations and regimens.
      Source IDH51-6D68F5FCD576A50F222A9BC7
      Populations
      1. Adult
        Source IDH51-28D15E024FBB842B5E91327D
      2. Pediatric
        Source IDH51-9E8C9F19189B54279BC4B50A
      3. Neonatal
        Source IDH51-FADBDE70A8AA86793CABFA1E
      Evidence tier
      Core reference - verify current label
      Source IDH51-49E06DC43B9BF2DBB6F37C96
      High alert
      true
      Source IDH51-99645610A740E38CB26DD954
      Hazardous
      false
      Source IDH51-EA58B7C8DA273D32AB6C22B6
      Status
      Active
      Source IDH51-DCC24CAB760F355F41BA121A
      Reviewed
      2026-08-29
      Source IDH51-CE2AFC0746945F4A90AC66A1
      Version added
      1.0
      Source IDH51-55C93E42BC9B5F0F04BDAED2
      Sources
      LabelUrlKind
      Source IDH51-2F1AE91F3191A6AA8889F501
      DailyMed label search
      Source IDH51-B48120EFF9270AB074592496
      https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Vasopressin (opens in a new tab)
      Source IDH51-1B971CFA47CD54F367FA4499
      Primary
      Source IDH51-4C7AD191E35471B6C315519F
      Source IDH51-C573A7F95DAA9D782E2FDCB7
      GlobalRPh legacy IV dilution monograph
      Source IDH51-B9CC9BBFD5C82C6569D4D33B
      legacy:auto
      Source IDH51-AC72F5198706B31ADFA98D51
      Legacy
      Source IDH51-2E4BEAB5C7844F407A6B1447
      Legacy title
      Vasopressin
      Source IDH51-D0088CD796879996FFF30DC0
      Clinical release verification
      Audit version
      3.4
      Source IDH51-7897F8A610602073B3CD489A
      Audited on
      2026-08-30
      Source IDH51-7A1CEC989B8ADF0566667562
      Level
      amber
      Source IDH51-88F2F475EF8E02716DFB7D61
      Release gate
      trusted_professional_source_present_exact_label_unconfirmed
      Source IDH51-B23FD3B7279EBF367EA478E9
      Exact current label candidate
      false
      Source IDH51-E4D79970181CBAB0D8966177
      Numeric support ratio
      0
      Source IDH51-D1179173AB5705A00F0A05EF
      Reference url count
      1
      Source IDH51-156A1E2A8109EB501E21A7CD
      Broken reference count
      0
      Source IDH51-3F72369F75BEBD7910266F43
      Point of use confirmation required
      true
      Source IDH51-06C45612389428F231AB73CA
      Note
      Do not treat this record as a fully current product-specific monograph until the exact IV formulation and current sources are confirmed.
      Source IDH51-D510D299915DB1712BEC41FD

      Dosing source fields

      Id
      vasopressin
      Source IDH51-4625457D4F15E339CE47EC3D
      Generic name
      Vasopressin
      Source IDH51-91006C916F712484E73EFBC2
      Coverage status
      direct_official_label_access_plus_local_snapshot
      Source IDH51-68784C56B80066F9C1750DC1
      Package insert
      Query name
      Vasopressin
      Source IDH51-681CCBA5EF3CA84B329ACCA9
      Product and route must match
      true
      Source IDH51-562ED03EE9AC8E3B8BAAF663
      Live current label enabled
      false
      Source IDH51-69C2485CE46D5FD41947C671
      Source priority
      Reviewed local summary when available, then a verified DailyMed label or product search when available, followed by professional references and institutional policy.
      Source IDH51-DEE05BA07DA1118196718566
      Direct official label access enabled
      true
      Source IDH51-2488A509F3A9A12138BD9D84
      Outbound server request required
      false
      Source IDH51-9D4FA76F81178CAA9D59615B
      Local summary status
      not_bundled
      Source IDH51-8E694F4C4D7F074FE27F09DB
      Clinical review
      Locally normalized
      false
      Source IDH51-0DF34B26976FFDDC9DAFD8EC
      Reviewed
      2026-08-29
      Source IDH51-B32FD40DFD93902E436C4F80
      Status
      Direct official package-insert access enabled; indication-specific local normalization pending.
      Source IDH51-0444D7B487EDEB0DDBB04DCF
      Clinical release verification
      Audit version
      3.4
      Source IDH51-EE1D0BA2EACDA087CDD26D1B
      Audited on
      2026-08-30
      Source IDH51-BE363FFCCE022A0EA6B238A9
      Level
      amber
      Source IDH51-A95478E853A2012B9DCED44C
      Release gate
      trusted_professional_source_present_exact_label_unconfirmed
      Source IDH51-141E01C192C7BBEC06EA032A
      Exact current label candidate
      false
      Source IDH51-DC929153FA2D1D2F4E382270
      Numeric support ratio
      0
      Source IDH51-B205960E84A1DEE876A5A03E
      Reference url count
      1
      Source IDH51-FDD95608C217D384F8AE6014
      Broken reference count
      0
      Source IDH51-8EBD8B797240213B32F0AABB
      Point of use confirmation required
      true
      Source IDH51-BB4E00A3C0895691E16BDE7E
      Note
      Do not treat this record as a fully current product-specific monograph until the exact IV formulation and current sources are confirmed.
      Source IDH51-B762D1577885C953AF50A6EC
      Historical preparation assessment

      Recovered v5.1 source content; historical, awaiting current review.

      Id
      vasopressin
      Source IDH51-C0CDB9A172FFB2CD96F126DA
      Name
      Vasopressin
      Source IDH51-78465972600E61AA812AEB16
      Brands
      Vasostrict | Pitressin
      Source IDH51-6DAA946414FBA0C6A33B3052
      Therapeutic class
      Cardiovascular and vasoactive
      Source IDH51-35F2C8DADD94D7C7EA51B2E5
      Review version
      3.1
      Source IDH51-C591AA9CCD3E6B6038006D9D
      Review date
      2026-08-30
      Source IDH51-AF84246B41F7C12FCDA83DB3
      Release status
      structured_record_current_label_not_confirmed
      Source IDH51-B7C3966F6A5A620538BEF465
      Market status
      Status
      no_current_us_iv_spl_confirmed
      Source IDH51-9968046722B980F8C8CF6032
      Basis
      No high-confidence current IV SPL was automatically selected; legacy information is segregated
      Source IDH51-2B5EDCE4F3D5E3DDAA272B24
      Ten point assessment
      Exact formulation
      Not established in the currently normalized record. Use the current-label panel before clinical use.
      Source IDH51-17D03BB03D8CFDFB3345D7A8
      Reconstitution concentration
      Dilute vial or use premix. Pharmacy-prepared standardized concentration.
      Source IDH51-89BD8E087CFA8DF8FCDDF1B9
      Maximum or recommended final concentration
      20 units/100 mL (0.2 unit/mL)
      Source IDH51-88294FAEF96B3C8683E01327
      Appropriate standardized containers
      100 mL Weight-appropriate volume
      Source IDH51-9BAB2DFAA587B3B8F54C4A79
      Adult dosing range
      Common bag 20 units Weight-based protocol 0.03 unit/min commonly
      Source IDH51-3EC60DFDD41BA2AF9CB56444
      Pediatric dosing range
      Not established in the currently normalized record. Use the current-label panel before clinical use.
      Source IDH51-A916CC6DFC06166E91CDA90B
      Neonatal dosing range
      Not established in the currently normalized record. Use the current-label panel before clinical use.
      Source IDH51-D3DBB5C2618640432F903463
      Infusion time
      Common fixed rate 0.03 unit/min Titrate or fixed rate per indication-specific protocol 0.03 unit/min commonly
      Source IDH51-41AE5CB17B028B10B5A80411
      Fluid restriction alternatives
      Not established in the currently normalized record. Use the current-label panel before clinical use.
      Source IDH51-6FADE8DD092879EA7998B825
      Current manufacturer labeling
      Match confidence
      unresolved
      Source IDH51-E70E0173935AC25CD1668559
      Field provenance
      Exact formulation
      Primary
      not_found
      Source IDH51-4D6DAA93CAC5906840FAB69D
      Reconstitution concentration
      Primary
      existing_structured_record
      Source IDH51-D35A86B331E83911D83B23C0
      Maximum or recommended final concentration
      Primary
      existing_structured_record
      Source IDH51-565CBDC443FB5A3935E52198
      Appropriate standardized containers
      Primary
      existing_structured_record
      Source IDH51-8AF4B04600E99736E65515F5
      Adult dosing range
      Primary
      existing_structured_record
      Source IDH51-8D67685162CF4D46546C3541
      Pediatric dosing range
      Primary
      not_found
      Source IDH51-A78364576B8D770B6D391569
      Neonatal dosing range
      Primary
      not_found
      Source IDH51-7C5CF50F13EF5F493D558D52
      Infusion time
      Primary
      existing_structured_record
      Source IDH51-6335F8B757BA7EA045955B14
      Fluid restriction alternatives
      Primary
      not_found
      Source IDH51-86D6CABD7FCD5503164C7879
      Current manufacturer labeling
      Primary
      DailyMed search gateway
      Source IDH51-3C4D813D1C1EEFF4FC34384B
      Population applicability
      Adult
      Applicability
      supported_or_source_present
      Source IDH51-8EFE649F80C54B75DDA1AA4C
      Guide generation allowed
      true
      Source IDH51-C82CF2A5D612A9BC76C917A1
      Pediatric
      Applicability
      supported_or_source_present
      Source IDH51-972EDC42628CDFF400160BAC
      Guide generation allowed
      false
      Source IDH51-69903D9E4019A6DF9B22EDE5
      Neonatal
      Applicability
      supported_or_source_present
      Source IDH51-38F110E1E4EB1767A9C7CA15
      Guide generation allowed
      false
      Source IDH51-9694AC89C5F8F97CC858DB3E
      Route presence
      Structured dilution
      true
      Source IDH51-AC30DB367577C30FDAB6603D
      Iv push
      false
      Source IDH51-1A0541A3200C01DFD1778966
      Continuous infusion
      true
      Source IDH51-3C58D68E9B7AC4E0894E349A
      Pediatric source
      true
      Source IDH51-C9BFE2EC5B176A7C5A5F409E
      Neonatal source
      true
      Source IDH51-85776A31D879591327A6B76E
      Legacy reference
      Status
      not_available
      Source IDH51-B1BE3AE5F94F2CE148BE774D
      Label resolution
      Status
      build_environment_network_unavailable
      Source IDH51-09F065DCB442CC66F7B96808
      Concentration values detected
      HighUnitText
      Source IDH51-64BEC000F141599AD14DC6F7
      0.2
      Source IDH51-74FAADD8D08EA26630428FD2
      unit
      Source IDH51-09A14150611CA71AD1F6939B
      0.2 unit/mL
      Source IDH51-F738FF37824D0F165C31981C
      Source files
      1. catalog.json
        Source IDH51-AA0BDC42C6AEDA6BD5456593
      2. dosing.json
        Source IDH51-BA68C5D71084FA7CE8090091
      3. legacy-map.json
        Source IDH51-A83B14ED52818F3F3A7792D6
      Clinical release note
      Preparation instructions are released only at the evidence level shown. Legacy content remains visibly separate. Exact product, NDC, route, current labeling, and institutional policy must be confirmed.
      Source IDH51-6EAA6D9FD01328C8435E0A28
      Historical statement IDs and source locations

      These IDs identify recovered source units. They are not evidence-qualified clinical claims.

      Historical IDOriginal source locationStatus
      H51-CD8AF9E8778288718B5FC435catalog.json
      /records/248/id
      Historical; current review incomplete
      H51-D2F4FF330F7BC6D5BF25C2FBcatalog.json
      /records/248/generic_name
      Historical; current review incomplete
      H51-1DBB98C254EF3B5208B36993catalog.json
      /records/248/brand_names/0
      Historical; current review incomplete
      H51-127B81CD3FB8DF9E45CF0A2Ccatalog.json
      /records/248/brand_names/1
      Historical; current review incomplete
      H51-9EABF5AB059E40DB6482F56Bcatalog.json
      /records/248/class
      Historical; current review incomplete
      H51-4C8E03117E46F908605B0314catalog.json
      /records/248/subclass
      Historical; current review incomplete
      H51-6D68F5FCD576A50F222A9BC7catalog.json
      /records/248/summary
      Historical; current review incomplete
      H51-3107A173A52FD75E3DAB6C3Acatalog.json
      /records/248/common_uses/0
      Historical; current review incomplete
      H51-8A443FD7B0C533323E33A423catalog.json
      /records/248/common_uses/1
      Historical; current review incomplete
      H51-8F87815B272899218CE6D087catalog.json
      /records/248/preparations/0
      Historical; current review incomplete
      H51-3D8EC35D9F4B4D3010AB5D19catalog.json
      /records/248/preparations/0/population
      Historical; current review incomplete
      H51-E52EAB0B942098245A981658catalog.json
      /records/248/preparations/0/amount
      Historical; current review incomplete
      H51-27C8D01645AD1D1A4B98BCDEcatalog.json
      /records/248/preparations/0/reconstitution
      Historical; current review incomplete
      H51-E0874F430E64E241371279C9catalog.json
      /records/248/preparations/0/diluent
      Historical; current review incomplete
      H51-CB37001990A6AF139E8CCEADcatalog.json
      /records/248/preparations/0/final_volume
      Historical; current review incomplete
      H51-6358E37A49026F22EAF552C6catalog.json
      /records/248/preparations/0/concentration
      Historical; current review incomplete
      H51-5315F14F5B11CF3E53444B10catalog.json
      /records/248/preparations/0/rate
      Historical; current review incomplete
      H51-679DF8714AE70071A859903Bcatalog.json
      /records/248/preparations/0/stability
      Historical; current review incomplete
      H51-04B84FC21C0E50D66F4499E5catalog.json
      /records/248/preparations/0/notes
      Historical; current review incomplete
      H51-71BC2188A660925F3B932E49catalog.json
      /records/248/preparations/1
      Historical; current review incomplete
      H51-7EF1599594CC48AB287E4696catalog.json
      /records/248/preparations/1/population
      Historical; current review incomplete
      H51-A179F98797F122C43A29B95Ecatalog.json
      /records/248/preparations/1/amount
      Historical; current review incomplete
      H51-1DF11664FF4B293022E017E7catalog.json
      /records/248/preparations/1/reconstitution
      Historical; current review incomplete
      H51-EF5B103D1A1100BB5A18EF6Ecatalog.json
      /records/248/preparations/1/diluent
      Historical; current review incomplete
      H51-AF0FF22C015116C574BDEAD3catalog.json
      /records/248/preparations/1/final_volume
      Historical; current review incomplete
      H51-011BAF2AEB94DF0C07A7A3EFcatalog.json
      /records/248/preparations/1/concentration
      Historical; current review incomplete
      H51-FEC09219C7048EC3222A888Ccatalog.json
      /records/248/preparations/1/rate
      Historical; current review incomplete
      H51-CE0C6C0881B86B7B9C94EDD5catalog.json
      /records/248/preparations/1/stability
      Historical; current review incomplete
      H51-8569720717D060A355C0886Bcatalog.json
      /records/248/preparations/1/notes
      Historical; current review incomplete
      H51-599D3E7EC6D93D8A49F442E6catalog.json
      /records/248/continuous_infusions/0
      Historical; current review incomplete
      H51-6C412FE8E5A27B96A46E596Acatalog.json
      /records/248/continuous_infusions/0/population
      Historical; current review incomplete
      H51-5589F16B01187B49FD39CF0Acatalog.json
      /records/248/continuous_infusions/0/standard_concentration
      Historical; current review incomplete
      H51-F81E8500AE648DD8F3EA56AFcatalog.json
      /records/248/continuous_infusions/0/initial_rate
      Historical; current review incomplete
      H51-C1E12750548938499D953695catalog.json
      /records/248/continuous_infusions/0/titration
      Historical; current review incomplete
      H51-1A1BB90DADC299D40189A686catalog.json
      /records/248/continuous_infusions/0/maximum
      Historical; current review incomplete
      H51-09BF97BC4975CA3DA637ACBAcatalog.json
      /records/248/continuous_infusions/0/notes
      Historical; current review incomplete
      H51-3DDE505FCC560D2F6749BB9Bcatalog.json
      /records/248/warnings/0
      Historical; current review incomplete
      H51-454115018F2D2A38371B8B84catalog.json
      /records/248/warnings/1
      Historical; current review incomplete
      H51-4BC7FFD537E2F242D24DA64Dcatalog.json
      /records/248/warnings/2
      Historical; current review incomplete
      H51-CA8ABDEB3FCEBBF4E26A6576catalog.json
      /records/248/monitoring/0
      Historical; current review incomplete
      H51-F84CD59D5E07EDE9D91FAD3Ccatalog.json
      /records/248/monitoring/1
      Historical; current review incomplete
      H51-588C4294C797684A51A77840catalog.json
      /records/248/monitoring/2
      Historical; current review incomplete
      H51-28D15E024FBB842B5E91327Dcatalog.json
      /records/248/populations/0
      Historical; current review incomplete
      H51-9E8C9F19189B54279BC4B50Acatalog.json
      /records/248/populations/1
      Historical; current review incomplete
      H51-FADBDE70A8AA86793CABFA1Ecatalog.json
      /records/248/populations/2
      Historical; current review incomplete
      H51-49E06DC43B9BF2DBB6F37C96catalog.json
      /records/248/evidence_tier
      Historical; current review incomplete
      H51-99645610A740E38CB26DD954catalog.json
      /records/248/high_alert
      Historical; current review incomplete
      H51-EA58B7C8DA273D32AB6C22B6catalog.json
      /records/248/hazardous
      Historical; current review incomplete
      H51-DCC24CAB760F355F41BA121Acatalog.json
      /records/248/status
      Historical; current review incomplete
      H51-CE2AFC0746945F4A90AC66A1catalog.json
      /records/248/reviewed
      Historical; current review incomplete
      H51-55C93E42BC9B5F0F04BDAED2catalog.json
      /records/248/version_added
      Historical; current review incomplete
      H51-2F1AE91F3191A6AA8889F501catalog.json
      /records/248/sources/0
      Historical; current review incomplete
      H51-B48120EFF9270AB074592496catalog.json
      /records/248/sources/0/label
      Historical; current review incomplete
      H51-1B971CFA47CD54F367FA4499catalog.json
      /records/248/sources/0/url
      Historical; current review incomplete
      H51-4C7AD191E35471B6C315519Fcatalog.json
      /records/248/sources/0/kind
      Historical; current review incomplete
      H51-C573A7F95DAA9D782E2FDCB7catalog.json
      /records/248/sources/1
      Historical; current review incomplete
      H51-B9CC9BBFD5C82C6569D4D33Bcatalog.json
      /records/248/sources/1/label
      Historical; current review incomplete
      H51-AC72F5198706B31ADFA98D51catalog.json
      /records/248/sources/1/url
      Historical; current review incomplete
      H51-2E4BEAB5C7844F407A6B1447catalog.json
      /records/248/sources/1/kind
      Historical; current review incomplete
      H51-D0088CD796879996FFF30DC0catalog.json
      /records/248/legacy_title
      Historical; current review incomplete
      H51-7897F8A610602073B3CD489Acatalog.json
      /records/248/clinical_release_verification/audit_version
      Historical; current review incomplete
      H51-7A1CEC989B8ADF0566667562catalog.json
      /records/248/clinical_release_verification/audited_on
      Historical; current review incomplete
      H51-88F2F475EF8E02716DFB7D61catalog.json
      /records/248/clinical_release_verification/level
      Historical; current review incomplete
      H51-B23FD3B7279EBF367EA478E9catalog.json
      /records/248/clinical_release_verification/release_gate
      Historical; current review incomplete
      H51-E4D79970181CBAB0D8966177catalog.json
      /records/248/clinical_release_verification/exact_current_label_candidate
      Historical; current review incomplete
      H51-5485594C99CD09E77C3A8B77catalog.json
      /records/248/clinical_release_verification/selected_setid
      Historical; current review incomplete
      H51-88E1A1699F937822A2404D35catalog.json
      /records/248/clinical_release_verification/selected_label_title
      Historical; current review incomplete
      H51-D1179173AB5705A00F0A05EFcatalog.json
      /records/248/clinical_release_verification/numeric_support_ratio
      Historical; current review incomplete
      H51-156A1E2A8109EB501E21A7CDcatalog.json
      /records/248/clinical_release_verification/reference_url_count
      Historical; current review incomplete
      H51-3F72369F75BEBD7910266F43catalog.json
      /records/248/clinical_release_verification/broken_reference_count
      Historical; current review incomplete
      H51-06C45612389428F231AB73CAcatalog.json
      /records/248/clinical_release_verification/point_of_use_confirmation_required
      Historical; current review incomplete
      H51-D510D299915DB1712BEC41FDcatalog.json
      /records/248/clinical_release_verification/note
      Historical; current review incomplete
      H51-620FE0A3FB3EC15BD7396AACcatalog.json
      /records/248/clinical_release_verification/dailymed_search_url
      Historical; current review incomplete
      H51-4625457D4F15E339CE47EC3Ddosing.json
      /records/248/id
      Historical; current review incomplete
      H51-91006C916F712484E73EFBC2dosing.json
      /records/248/generic_name
      Historical; current review incomplete
      H51-68784C56B80066F9C1750DC1dosing.json
      /records/248/coverage_status
      Historical; current review incomplete
      H51-681CCBA5EF3CA84B329ACCA9dosing.json
      /records/248/package_insert/query_name
      Historical; current review incomplete
      H51-E2D793F174A06BE134F42310dosing.json
      /records/248/package_insert/preferred_setid
      Historical; current review incomplete
      H51-562ED03EE9AC8E3B8BAAF663dosing.json
      /records/248/package_insert/product_and_route_must_match
      Historical; current review incomplete
      H51-69C2485CE46D5FD41947C671dosing.json
      /records/248/package_insert/live_current_label_enabled
      Historical; current review incomplete
      H51-DEE05BA07DA1118196718566dosing.json
      /records/248/package_insert/source_priority
      Historical; current review incomplete
      H51-2488A509F3A9A12138BD9D84dosing.json
      /records/248/package_insert/direct_official_label_access_enabled
      Historical; current review incomplete
      H51-9D4FA76F81178CAA9D59615Bdosing.json
      /records/248/package_insert/outbound_server_request_required
      Historical; current review incomplete
      H51-8E694F4C4D7F074FE27F09DBdosing.json
      /records/248/package_insert/local_summary_status
      Historical; current review incomplete
      H51-61335D390115D6D487C96ECDdosing.json
      /records/248/renal/classification
      Historical; current review incomplete
      H51-749CA8C9A2EDC0D692D527ADdosing.json
      /records/248/renal/summary
      Historical; current review incomplete
      H51-08D463AF1900879AB53927EDdosing.json
      /records/248/renal/method_note
      Historical; current review incomplete
      H51-8D9194CF36140A96EABA7B0Adosing.json
      /records/248/existing_route_snapshots/0
      Historical; current review incomplete
      H51-43A3FF06BDD7B225088C59D1dosing.json
      /records/248/existing_route_snapshots/0/route
      Historical; current review incomplete
      H51-529A2C032E485F1535C5A49Adosing.json
      /records/248/existing_route_snapshots/0/population
      Historical; current review incomplete
      H51-0639425B53531B68E9BF7742dosing.json
      /records/248/existing_route_snapshots/0/indication
      Historical; current review incomplete
      H51-3334F138C4439404A1B7D38Bdosing.json
      /records/248/existing_route_snapshots/0/dose
      Historical; current review incomplete
      H51-493AB528BA0367515DAB666Bdosing.json
      /records/248/existing_route_snapshots/0/interval
      Historical; current review incomplete
      H51-A142C45539B46827767F69B0dosing.json
      /records/248/existing_route_snapshots/0/duration
      Historical; current review incomplete
      H51-D8FA0ED7A4AAA1164CF7D5B4dosing.json
      /records/248/existing_route_snapshots/0/administration
      Historical; current review incomplete
      H51-2437E9EF66532F24BBC69C8Fdosing.json
      /records/248/existing_route_snapshots/0/source_level
      Historical; current review incomplete
      H51-F0A73D346CAB6B0F1050A283dosing.json
      /records/248/existing_route_snapshots/0/notes
      Historical; current review incomplete
      H51-76D35FC5190376DF7AEA8033dosing.json
      /records/248/existing_route_snapshots/1
      Historical; current review incomplete
      H51-E639EAA007A96140C730E7F8dosing.json
      /records/248/existing_route_snapshots/1/route
      Historical; current review incomplete
      H51-19B29C528D55F3228C46CA82dosing.json
      /records/248/existing_route_snapshots/1/population
      Historical; current review incomplete
      H51-D983480CE0C15AFE25F84096dosing.json
      /records/248/existing_route_snapshots/1/indication
      Historical; current review incomplete
      H51-B75840327126F4510990E064dosing.json
      /records/248/existing_route_snapshots/1/dose
      Historical; current review incomplete
      H51-632FC394C82A98666F77F3E4dosing.json
      /records/248/existing_route_snapshots/1/interval
      Historical; current review incomplete
      H51-273328EC7281385767A433C8dosing.json
      /records/248/existing_route_snapshots/1/duration
      Historical; current review incomplete
      H51-41EA86F535F4FA7F5EBEA23Cdosing.json
      /records/248/existing_route_snapshots/1/administration
      Historical; current review incomplete
      H51-7D1CA5C2B00DA6EDEAA0D1AEdosing.json
      /records/248/existing_route_snapshots/1/source_level
      Historical; current review incomplete
      H51-FAAD7879B6C70F20505C9A8Ddosing.json
      /records/248/existing_route_snapshots/1/notes
      Historical; current review incomplete
      H51-CE12BD59697D4889CB5F1D46dosing.json
      /records/248/existing_route_snapshots/2
      Historical; current review incomplete
      H51-8A46714D2B6AB537FECF39A3dosing.json
      /records/248/existing_route_snapshots/2/route
      Historical; current review incomplete
      H51-859E51EC8022D7BA338525F4dosing.json
      /records/248/existing_route_snapshots/2/population
      Historical; current review incomplete
      H51-1846916BD5A6687707800179dosing.json
      /records/248/existing_route_snapshots/2/indication
      Historical; current review incomplete
      H51-8AE642274A60AC2120B1F9B7dosing.json
      /records/248/existing_route_snapshots/2/dose
      Historical; current review incomplete
      H51-7AE4DAF9ABFBE69926AEF0F4dosing.json
      /records/248/existing_route_snapshots/2/interval
      Historical; current review incomplete
      H51-220B7C80F355E8039E10D60Ddosing.json
      /records/248/existing_route_snapshots/2/duration
      Historical; current review incomplete
      H51-6EA7410B6F31DCEF61069527dosing.json
      /records/248/existing_route_snapshots/2/administration
      Historical; current review incomplete
      H51-D378C00E30F10F6CD8F9E037dosing.json
      /records/248/existing_route_snapshots/2/source_level
      Historical; current review incomplete
      H51-D739616FDCED51596F2FAE7Fdosing.json
      /records/248/existing_route_snapshots/2/notes
      Historical; current review incomplete
      H51-0DF34B26976FFDDC9DAFD8ECdosing.json
      /records/248/clinical_review/locally_normalized
      Historical; current review incomplete
      H51-B32FD40DFD93902E436C4F80dosing.json
      /records/248/clinical_review/reviewed
      Historical; current review incomplete
      H51-0444D7B487EDEB0DDBB04DCFdosing.json
      /records/248/clinical_review/status
      Historical; current review incomplete
      H51-EE1D0BA2EACDA087CDD26D1Bdosing.json
      /records/248/clinical_release_verification/audit_version
      Historical; current review incomplete
      H51-BE363FFCCE022A0EA6B238A9dosing.json
      /records/248/clinical_release_verification/audited_on
      Historical; current review incomplete
      H51-A95478E853A2012B9DCED44Cdosing.json
      /records/248/clinical_release_verification/level
      Historical; current review incomplete
      H51-141E01C192C7BBEC06EA032Adosing.json
      /records/248/clinical_release_verification/release_gate
      Historical; current review incomplete
      H51-DC929153FA2D1D2F4E382270dosing.json
      /records/248/clinical_release_verification/exact_current_label_candidate
      Historical; current review incomplete
      H51-8BF9B2C549D40E044DDA93CAdosing.json
      /records/248/clinical_release_verification/selected_setid
      Historical; current review incomplete
      H51-C27C13A667D1D0B5AEFFF66Ddosing.json
      /records/248/clinical_release_verification/selected_label_title
      Historical; current review incomplete
      H51-B205960E84A1DEE876A5A03Edosing.json
      /records/248/clinical_release_verification/numeric_support_ratio
      Historical; current review incomplete
      H51-FDD95608C217D384F8AE6014dosing.json
      /records/248/clinical_release_verification/reference_url_count
      Historical; current review incomplete
      H51-8EBD8B797240213B32F0AABBdosing.json
      /records/248/clinical_release_verification/broken_reference_count
      Historical; current review incomplete
      H51-BB4E00A3C0895691E16BDE7Edosing.json
      /records/248/clinical_release_verification/point_of_use_confirmation_required
      Historical; current review incomplete
      H51-B762D1577885C953AF50A6ECdosing.json
      /records/248/clinical_release_verification/note
      Historical; current review incomplete
      H51-D4FA5089DD3D5FD282FA5C25dosing.json
      /records/248/clinical_release_verification/dailymed_search_url
      Historical; current review incomplete
      H51-380EE1528268766573D5D1D6first-look-v5.1.json
      /records/248/id
      Historical; current review incomplete
      H51-5CFC6F6CAAD86E99087CCB85first-look-v5.1.json
      /records/248/generic_name
      Historical; current review incomplete
      H51-B0BC4FF72E24C11883B1E462first-look-v5.1.json
      /records/248/class
      Historical; current review incomplete
      H51-F0CADFE54AB210D05F7354E1first-look-v5.1.json
      /records/248/subclass
      Historical; current review incomplete
      H51-0875F1126AF86637CD369DCDfirst-look-v5.1.json
      /records/248/primary_uses/0
      Historical; current review incomplete
      H51-83E050BFE535ECF049E0AE30first-look-v5.1.json
      /records/248/primary_uses/1
      Historical; current review incomplete
      H51-1E111492EBCBE3CF7AE4518Efirst-look-v5.1.json
      /records/248/mechanism
      Historical; current review incomplete
      H51-34DAC26CB8EE9F4C1DC73100first-look-v5.1.json
      /records/248/mechanism_level
      Historical; current review incomplete
      H51-65FDC08A4549D8BEAA18A47Ffirst-look-v5.1.json
      /records/248/basic_dosing_orientation
      Historical; current review incomplete
      H51-5E02C706B9A5364FD775139Bfirst-look-v5.1.json
      /records/248/administration_orientation
      Historical; current review incomplete
      H51-D1A5FCA936421F5407018FACfirst-look-v5.1.json
      /records/248/renal_and_population_orientation
      Historical; current review incomplete
      H51-76CC53255019A4C6C2BCDB48first-look-v5.1.json
      /records/248/key_safety_orientation/0
      Historical; current review incomplete
      H51-4992ECEE8CAD216847A77AD0first-look-v5.1.json
      /records/248/key_safety_orientation/1
      Historical; current review incomplete
      H51-D475572FE4F34E3B92DA1613first-look-v5.1.json
      /records/248/key_safety_orientation/2
      Historical; current review incomplete
      H51-DD624643CAED2254A188A791first-look-v5.1.json
      /records/248/coverage_path
      Historical; current review incomplete
      H51-B93784ACE3FECCCDB1D0BFF4first-look-v5.1.json
      /records/248/coverage_path_label
      Historical; current review incomplete
      H51-064101D8CD590EB91DCA5A5Ffirst-look-v5.1.json
      /records/248/official_label_url
      Historical; current review incomplete
      H51-6C516B977EF183332BD95053first-look-v5.1.json
      /records/248/legacy_title
      Historical; current review incomplete
      H51-9D7FF592AB1887658C4674E8first-look-v5.1.json
      /records/248/review_note
      Historical; current review incomplete
      H51-2FBF341047D4A3C7AAAF9AE4first-look-v5.1.json
      /records/248/search_text
      Historical; current review incomplete
      H51-BDC505BBF541CA0309017D69first-look-v5.1.json
      /records/248/official_search_url
      Historical; current review incomplete
      H51-C6DE719B9902CE0A93EFD146first-look-v5.1.json
      /records/248/official_access_mode
      Historical; current review incomplete
      H51-31BD59D463A371EE14DDEA19first-look-v5.1.json
      /records/248/official_access_url
      Historical; current review incomplete
      H51-5AECCE55747F664F68079C99first-look-v5.1.json
      /records/248/official_search_query
      Historical; current review incomplete
      H51-31635B2C157347DBEB80CBCBfirst-look-v5.1.json
      /records/248/official_access_reason
      Historical; current review incomplete
      H51-C0CDB9A172FFB2CD96F126DApreparation-assessments-v3.8.json
      /248/id
      Historical; current review incomplete
      H51-78465972600E61AA812AEB16preparation-assessments-v3.8.json
      /248/name
      Historical; current review incomplete
      H51-6DAA946414FBA0C6A33B3052preparation-assessments-v3.8.json
      /248/brands
      Historical; current review incomplete
      H51-35F2C8DADD94D7C7EA51B2E5preparation-assessments-v3.8.json
      /248/therapeutic_class
      Historical; current review incomplete
      H51-C591AA9CCD3E6B6038006D9Dpreparation-assessments-v3.8.json
      /248/review_version
      Historical; current review incomplete
      H51-AF84246B41F7C12FCDA83DB3preparation-assessments-v3.8.json
      /248/review_date
      Historical; current review incomplete
      H51-B7C3966F6A5A620538BEF465preparation-assessments-v3.8.json
      /248/release_status
      Historical; current review incomplete
      H51-9968046722B980F8C8CF6032preparation-assessments-v3.8.json
      /248/market_status/status
      Historical; current review incomplete
      H51-2B5EDCE4F3D5E3DDAA272B24preparation-assessments-v3.8.json
      /248/market_status/basis
      Historical; current review incomplete
      H51-17D03BB03D8CFDFB3345D7A8preparation-assessments-v3.8.json
      /248/ten_point_assessment/exact_formulation
      Historical; current review incomplete
      H51-89BD8E087CFA8DF8FCDDF1B9preparation-assessments-v3.8.json
      /248/ten_point_assessment/reconstitution_concentration
      Historical; current review incomplete
      H51-88294FAEF96B3C8683E01327preparation-assessments-v3.8.json
      /248/ten_point_assessment/maximum_or_recommended_final_concentration
      Historical; current review incomplete
      H51-9BAB2DFAA587B3B8F54C4A79preparation-assessments-v3.8.json
      /248/ten_point_assessment/appropriate_standardized_containers
      Historical; current review incomplete
      H51-3EC60DFDD41BA2AF9CB56444preparation-assessments-v3.8.json
      /248/ten_point_assessment/adult_dosing_range
      Historical; current review incomplete
      H51-A916CC6DFC06166E91CDA90Bpreparation-assessments-v3.8.json
      /248/ten_point_assessment/pediatric_dosing_range
      Historical; current review incomplete
      H51-D3DBB5C2618640432F903463preparation-assessments-v3.8.json
      /248/ten_point_assessment/neonatal_dosing_range
      Historical; current review incomplete
      H51-41AE5CB17B028B10B5A80411preparation-assessments-v3.8.json
      /248/ten_point_assessment/infusion_time
      Historical; current review incomplete
      H51-6FADE8DD092879EA7998B825preparation-assessments-v3.8.json
      /248/ten_point_assessment/fluid_restriction_alternatives
      Historical; current review incomplete
      H51-9087A48A517AFEE4386896C3preparation-assessments-v3.8.json
      /248/ten_point_assessment/current_manufacturer_labeling/setid
      Historical; current review incomplete
      H51-77885060314E2702E1319DA4preparation-assessments-v3.8.json
      /248/ten_point_assessment/current_manufacturer_labeling/title
      Historical; current review incomplete
      H51-6E83791EE3F713AF7E6DA892preparation-assessments-v3.8.json
      /248/ten_point_assessment/current_manufacturer_labeling/published_date
      Historical; current review incomplete
      H51-7A0D03BEC91E43158CAC6B08preparation-assessments-v3.8.json
      /248/ten_point_assessment/current_manufacturer_labeling/manufacturer
      Historical; current review incomplete
      H51-E70E0173935AC25CD1668559preparation-assessments-v3.8.json
      /248/ten_point_assessment/current_manufacturer_labeling/match_confidence
      Historical; current review incomplete
      H51-B258B92D965F87EE90068847preparation-assessments-v3.8.json
      /248/ten_point_assessment/current_manufacturer_labeling/url
      Historical; current review incomplete
      H51-4D6DAA93CAC5906840FAB69Dpreparation-assessments-v3.8.json
      /248/field_provenance/exact_formulation/primary
      Historical; current review incomplete
      H51-D35A86B331E83911D83B23C0preparation-assessments-v3.8.json
      /248/field_provenance/reconstitution_concentration/primary
      Historical; current review incomplete
      H51-565CBDC443FB5A3935E52198preparation-assessments-v3.8.json
      /248/field_provenance/maximum_or_recommended_final_concentration/primary
      Historical; current review incomplete
      H51-8AF4B04600E99736E65515F5preparation-assessments-v3.8.json
      /248/field_provenance/appropriate_standardized_containers/primary
      Historical; current review incomplete
      H51-8D67685162CF4D46546C3541preparation-assessments-v3.8.json
      /248/field_provenance/adult_dosing_range/primary
      Historical; current review incomplete
      H51-A78364576B8D770B6D391569preparation-assessments-v3.8.json
      /248/field_provenance/pediatric_dosing_range/primary
      Historical; current review incomplete
      H51-7C5CF50F13EF5F493D558D52preparation-assessments-v3.8.json
      /248/field_provenance/neonatal_dosing_range/primary
      Historical; current review incomplete
      H51-6335F8B757BA7EA045955B14preparation-assessments-v3.8.json
      /248/field_provenance/infusion_time/primary
      Historical; current review incomplete
      H51-86D6CABD7FCD5503164C7879preparation-assessments-v3.8.json
      /248/field_provenance/fluid_restriction_alternatives/primary
      Historical; current review incomplete
      H51-3C4D813D1C1EEFF4FC34384Bpreparation-assessments-v3.8.json
      /248/field_provenance/current_manufacturer_labeling/primary
      Historical; current review incomplete
      H51-8EFE649F80C54B75DDA1AA4Cpreparation-assessments-v3.8.json
      /248/population_applicability/adult/applicability
      Historical; current review incomplete
      H51-C82CF2A5D612A9BC76C917A1preparation-assessments-v3.8.json
      /248/population_applicability/adult/guide_generation_allowed
      Historical; current review incomplete
      H51-972EDC42628CDFF400160BACpreparation-assessments-v3.8.json
      /248/population_applicability/pediatric/applicability
      Historical; current review incomplete
      H51-69903D9E4019A6DF9B22EDE5preparation-assessments-v3.8.json
      /248/population_applicability/pediatric/guide_generation_allowed
      Historical; current review incomplete
      H51-38F110E1E4EB1767A9C7CA15preparation-assessments-v3.8.json
      /248/population_applicability/neonatal/applicability
      Historical; current review incomplete
      H51-9694AC89C5F8F97CC858DB3Epreparation-assessments-v3.8.json
      /248/population_applicability/neonatal/guide_generation_allowed
      Historical; current review incomplete
      H51-AC30DB367577C30FDAB6603Dpreparation-assessments-v3.8.json
      /248/route_presence/structured_dilution
      Historical; current review incomplete
      H51-1A0541A3200C01DFD1778966preparation-assessments-v3.8.json
      /248/route_presence/iv_push
      Historical; current review incomplete
      H51-3C58D68E9B7AC4E0894E349Apreparation-assessments-v3.8.json
      /248/route_presence/continuous_infusion
      Historical; current review incomplete
      H51-C9BFE2EC5B176A7C5A5F409Epreparation-assessments-v3.8.json
      /248/route_presence/pediatric_source
      Historical; current review incomplete
      H51-85776A31D879591327A6B76Epreparation-assessments-v3.8.json
      /248/route_presence/neonatal_source
      Historical; current review incomplete
      H51-B1BE3AE5F94F2CE148BE774Dpreparation-assessments-v3.8.json
      /248/legacy_reference/status
      Historical; current review incomplete
      H51-09F065DCB442CC66F7B96808preparation-assessments-v3.8.json
      /248/label_resolution/status
      Historical; current review incomplete
      H51-64BEC000F141599AD14DC6F7preparation-assessments-v3.8.json
      /248/concentration_values_detected/0
      Historical; current review incomplete
      H51-B331637562C091527277FCC5preparation-assessments-v3.8.json
      /248/concentration_values_detected/0/low
      Historical; current review incomplete
      H51-74FAADD8D08EA26630428FD2preparation-assessments-v3.8.json
      /248/concentration_values_detected/0/high
      Historical; current review incomplete
      H51-09A14150611CA71AD1F6939Bpreparation-assessments-v3.8.json
      /248/concentration_values_detected/0/unit
      Historical; current review incomplete
      H51-F738FF37824D0F165C31981Cpreparation-assessments-v3.8.json
      /248/concentration_values_detected/0/text
      Historical; current review incomplete
      H51-AA0BDC42C6AEDA6BD5456593preparation-assessments-v3.8.json
      /248/source_files/0
      Historical; current review incomplete
      H51-BA68C5D71084FA7CE8090091preparation-assessments-v3.8.json
      /248/source_files/1
      Historical; current review incomplete
      H51-A83B14ED52818F3F3A7792D6preparation-assessments-v3.8.json
      /248/source_files/2
      Historical; current review incomplete
      H51-6EAA6D9FD01328C8435E0A28preparation-assessments-v3.8.json
      /248/clinical_release_note
      Historical; current review incomplete